Ender Kurt
Impact in
-
- Cancer Treatment and Pharmacology
- Inflammatory Biomarkers in Disease Prognosis
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
Papers in
- Oncology 20
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 6
- HER2/EGFR in Cancer Research 4
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 4
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Türkkan Evrensel (27 shared papers)Osman Manavoğlu (18 shared papers)Özkan Kanat (18 shared papers)Güzin Gönüllü (9 shared papers)Mutlu Demiray (12 shared papers)Ahmet Tunalı (1 shared paper)Vildan Özkocaman (1 shared paper)Ömer Yerci (2 shared papers)
- Journals
- Clinical & Translational Oncology (2 papers)Medical Oncology (2 papers)Journal of Clinical Oncology (2 papers)Cancer Investigation (2 papers)SpringerPlus (1 paper)
- Partner nations
- Türkiye
In The Last Decade
Ender Kurt
32 papers receiving 363 citations
Peers
Comparison fields: 5 of 69
- Oncology 217
- Chemical Health and Safety 4
- Emergency Medicine 51
- Cancer Research 72
- Hematology 35
Countries citing papers authored by Ender Kurt
This map shows the geographic impact of Ender Kurt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ender Kurt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ender Kurt more than expected).
Fields of papers citing papers by Ender Kurt
This network shows the impact of papers produced by Ender Kurt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ender Kurt. The network helps show where Ender Kurt may publish in the future.
Co-authors
The 25 scholars most cited alongside Ender Kurt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 96 | |
| 2 | 2003 | 36 | |
| 3 | 2005 | 21 | |
| 4 | 2003 | 21 | |
| 5 | 2012 | 19 | |
| 6 | 2003 | 19 | |
| 7 | 2007 | 15 | |
| 8 | 2006 | 14 | |
| 9 | 2006 | 14 | |
| 10 | 2011 | 14 | |
| 11 | 2005 | 13 | |
| 12 | 2012 | 12 | |
| 13 | 2003 | 12 | |
| 14 | Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy. | 2015 | 9 |
| 15 | 2005 | 8 | |
| 16 | 2015 | 8 | |
| 17 | 2005 | 6 | |
| 18 | 2004 | 6 | |
| 19 | 2004 | 6 | |
| 20 | Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer. | 2013 | 5 |
About Ender Kurt
Ender Kurt is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 33 papers that have together received 380 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Colorectal Cancer Treatments and Studies (6 papers), HER2/EGFR in Cancer Research (4 papers), Lung Cancer Research Studies (4 papers), Cancer Genomics and Diagnostics (4 papers), Peptidase Inhibition and Analysis (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Oncology (217 citations), Chemical Health and Safety (4 citations), Emergency Medicine (51 citations), Cancer Research (72 citations) and Hematology (35 citations). Ender Kurt has collaborated with scholars based in Türkiye. Frequent co-authors include Türkkan Evrensel, Osman Manavoğlu, Özkan Kanat, Güzin Gönüllü, Mutlu Demiray, Ahmet Tunalı, Vildan Özkocaman, Ömer Yerci, Hülya Öztürk and Fahir Özkalemkaş. Their work appears in journals such as Clinical & Translational Oncology, Medical Oncology, Journal of Clinical Oncology, Cancer Investigation and SpringerPlus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.